JP2020535203A5 - - Google Patents

Download PDF

Info

Publication number
JP2020535203A5
JP2020535203A5 JP2020518033A JP2020518033A JP2020535203A5 JP 2020535203 A5 JP2020535203 A5 JP 2020535203A5 JP 2020518033 A JP2020518033 A JP 2020518033A JP 2020518033 A JP2020518033 A JP 2020518033A JP 2020535203 A5 JP2020535203 A5 JP 2020535203A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
nucleotide sequence
sequence encoding
fragment
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020518033A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020535203A (ja
JP7178118B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2018/011529 external-priority patent/WO2019066556A1/ko
Publication of JP2020535203A publication Critical patent/JP2020535203A/ja
Publication of JP2020535203A5 publication Critical patent/JP2020535203A5/ja
Application granted granted Critical
Publication of JP7178118B2 publication Critical patent/JP7178118B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020518033A 2017-09-29 2018-09-28 不整脈を予防または治療するための医薬組成物 Active JP7178118B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2017-0127550 2017-09-29
KR20170127550 2017-09-29
PCT/KR2018/011529 WO2019066556A1 (ko) 2017-09-29 2018-09-28 심장 부정맥의 예방 또는 치료용 약학적 조성물

Publications (3)

Publication Number Publication Date
JP2020535203A JP2020535203A (ja) 2020-12-03
JP2020535203A5 true JP2020535203A5 (enExample) 2021-11-04
JP7178118B2 JP7178118B2 (ja) 2022-11-25

Family

ID=65902177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020518033A Active JP7178118B2 (ja) 2017-09-29 2018-09-28 不整脈を予防または治療するための医薬組成物

Country Status (6)

Country Link
US (1) US11761019B2 (enExample)
EP (1) EP3689363A4 (enExample)
JP (1) JP7178118B2 (enExample)
KR (2) KR102916658B1 (enExample)
CN (1) CN111542334B (enExample)
WO (1) WO2019066556A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7240749B2 (ja) * 2017-09-29 2023-03-16 ベスファジェン・インコーポレイテッド 心不全の予防または治療のための医薬組成物
EP4722234A1 (en) * 2023-06-05 2026-04-08 BethphaGen Inc. Gene construct comprising nucleotides encoding decoy peptides for inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban and nucleotides encoding ccn5 protein or fragments thereof, and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US20090239940A1 (en) * 1997-07-22 2009-09-24 Del Monte Federica Treating heart failure and ventricular arrhythmias
EP1382347A1 (en) * 2002-07-17 2004-01-21 UNIVERSITE PARIS 7 - Denis DIDEROT Use of CCN protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux
US20040106954A1 (en) * 2002-11-15 2004-06-03 Whitehurst Todd K. Treatment of congestive heart failure
US20060079445A1 (en) * 2004-06-16 2006-04-13 Pitt Geoffrey S CaMKII/calcium channel binding-related compositions and methods
KR101187814B1 (ko) * 2010-03-22 2012-10-08 광주과학기술원 심부전 예방 또는 치료용 약제학적 조성물 및 심부전 예방 또는 치료제의 스크리닝 방법
BR112015030355A8 (pt) * 2013-06-07 2019-12-24 Univ California uso de uma proteína ou um polipeptídeo de adenilil ciclase tipo 6 (ac6) incompetente com a adenosina monofosfato cíclico (incompetente com camp) ou um gene ou ácido nucléico que codifica ac6mut, e, formulação
WO2017082701A1 (ko) * 2015-11-13 2017-05-18 (주)벳바젠 심장 섬유증 치료용 약제학적 조성물

Similar Documents

Publication Publication Date Title
JP2020073536A5 (enExample)
JP2020203894A5 (enExample)
ES2387082T3 (es) Uso de OSTEOPONTINA para el tratamiento y/o prevención de enfermedades neurológicas
JP2011525363A5 (enExample)
JP2018524393A5 (enExample)
JP2020519292A5 (enExample)
JP2023517934A5 (enExample)
US20240002462A1 (en) Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs
JP2017523239A5 (enExample)
JP2006502702A5 (enExample)
JP2018509154A5 (enExample)
JP2018537089A5 (enExample)
JP2023509118A5 (enExample)
JP2004501650A5 (enExample)
JP2021533801A5 (enExample)
JP2003503355A5 (enExample)
JP2019521692A5 (enExample)
US20150118187A1 (en) Micro-organs providing sustained delivery of a therapeutic polypeptide and methods of use thereof
Guo et al. Molecular cloning and characterization of a novel bovine IFN-ε
JP2005508158A5 (enExample)
JP2006511212A5 (enExample)
JP2020536519A5 (enExample)
JP2019070001A (ja) 肝細胞増殖因子及びストローマ細胞由来因子1αを用いた末梢動脈疾患の予防または治療用組成物
O'Neill et al. Comparison of SNCG and NEFH promoter–driven expression of human SIRT1 expression in a mouse model of glaucoma
JP2019525764A5 (enExample)